Stem Cell Therapy for Osteoarthritis Market Report 2025 (Global Edition)

Global Stem Cell Therapy for Osteoarthritis Market Report 2025 Market Size Split by Type (Primary Osteoarthritis, Secondary Osteoarthritis), by Therapy Type (Monotherapy, Combination therapy), by Appl...

Stem Cell Therapy for Osteoarthritis Market Report Description

We have various report editions of Stem Cell Therapy for Osteoarthritis Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Stem Cell Therapy for Osteoarthritis Market Insights Video

Competitive Landscape of the Stem Cell Therapy for Osteoarthritis Market

The competitive landscape of the Stem Cell Therapy for Osteoarthritis market is characterized by a diverse range of players competing to gain market share through product innovation, strategic partnerships, and aggressive marketing efforts. Key players in the market include established medical device manufacturers, specialized Stem Cell Therapy for Osteoarthritis companies, and emerging start-ups aiming to disrupt the market with innovative solutions.

April 2024: A collaboration between SCG Cell Therapy (SCG) and the Agency for Science, Technology, and Research in Singapore has allowed for significant advancements in the production of induced pluripotent stem cells (iPSCs) that comply with good manufacturing practices (GMP) regulations. (Source:https://www.scgcell.com/newsinfo/7056618.html)

Top Companies Market Share in Stem Cell Therapy for Osteoarthritis Industry: (In no particular order of Rank)

• Medipost
• Nature Cell
• Takeda (TiGenix)
• Theracell Advanced Biotechnology
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Stem Cell Therapy for Osteoarthritis Market

Which Region Dominates the Stem Cell Therapy for Osteoarthritis Market in 2024?

According to Cognitive Market Research, North America led the market in 2024, accounting for almost 40% of worldwide sales. Due to a number of important factors, North America is anticipated to lead the growth of the market for osteoarthritis stem cell therapy. This expansion is attributed to the region's high prevalence of osteoarthritis, substantial investment in research and development, and sophisticated healthcare infrastructure. Leading biotech companies and favorable regulatory environments also help to advance the creation and broader adoption of novel treatments. The benefits of stem cell treatments are becoming more widely known to patients and healthcare professionals, which is driving up market demand. Consequently, North America is positioned to play a significant role in propelling the global market expansion for stem cell therapy for osteoarthritis.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific stands out as the fastest-growing region in the Stem Cell Therapy for Osteoarthritis market. The market for stem cell therapy for osteoarthritis is expected to expand fastest in the Asia Pacific area for a number of reasons. A growing number of older people are developing osteoarthritis, which is a major motivator, along with rapidly advancing healthcare spending and infrastructure. Further propelling market expansion is encouraging government policies, more funding for biomedical research, and a surge in clinical trials in nations like South Korea, China, and Japan. The market is growing because people and Healthcare practitioners are becoming increasingly conscious of and tolerant of innovative medicines. It follows that a major contribution to the worldwide growth of stem cell therapy for osteoarthritis is anticipated from the Asia Pacific region.

The current report Scope analyzes Stem Cell Therapy for Osteoarthritis Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Stem Cell Therapy for Osteoarthritis Market Analysis

According to Cognitive Market Research, the global Stem Cell Therapy for Osteoarthritis market size was estimated at USD 29.5 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 11.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 23.8% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Stem Cell Therapy for Osteoarthritis market with a market size of USD 9.31 million in 2024 and is projected to grow at a CAGR of 23.6% during the forecast period. The aging population in the United States is a key contributing cause of osteoarthritis. This opens up a sizable market for stem cell therapy as a therapeutic approach.
• The Canada Stem Cell Therapy for Osteoarthritis market had a market share of USD 1.42 million in 2024 and is projected to grow at a CAGR of 24.6% during the forecast period. The Canadian government funds research and development in the field of regenerative medicine, including stem cell therapy for osteoarthritis, since it acknowledges the promising potential of this subject.
• The Mexico Stem Cell Therapy for Osteoarthritis market is projected to witness growth at a CAGR of 24.3% during the forecast period, with a market size of USD 1.07 million in 2024.

Europe Stem Cell Therapy for Osteoarthritis Market Analysis

According to Cognitive Market Research, the global Stem Cell Therapy for Osteoarthritis market size was estimated at USD 29.5 Million, out of which Europe held the market of more than 30% of the global revenue with a market size of USD 8.85 million in 2024 and will grow at a compound annual growth rate (CAGR) of 24.1% from 2024 to 2031.

• The United Kingdom Stem Cell Therapy for Osteoarthritis market had a market share of USD 1.49 million in 2024 and is projected to grow at a CAGR of 24.9% during the forecast period. Renowned research institutes and a highly qualified scientific community are found in the UK, and they are actively involved in stem cell therapy research, including its potential uses in the treatment of osteoarthritis.
• The France Stem Cell Therapy for Osteoarthritis market is projected to witness growth at a CAGR of 23.3% during the forecast period, with a market size of USD 0.81 million in 2024.
• According to Cognitive Market Research, the German Stem Cell Therapy for Osteoarthritis market size was valued at USD 1.75 million in 2024 and is projected to grow at a CAGR of 24.3% during the forecast period. Germany is home to a top-notch healthcare system with top-notch research centers, knowledgeable medical personnel, and well-equipped facilities. With this robust infrastructure, osteoarthritis stem cell therapies can be adopted and implemented with ease.
• The Italy Stem Cell Therapy for Osteoarthritis market is projected to witness growth at a CAGR of 23.5% during the forecast period, with a market size of USD 0.76 million in 2024.
• The Russia Stem Cell Therapy for Osteoarthritis market is projected to witness growth at a CAGR of 23.1% during the forecast period, with a market size of USD 1.37 million in 2024.
• The Spain Stem Cell Therapy for Osteoarthritis market is projected to witness growth at a CAGR of 23.2% during the forecast period with a market size of USD 0.73 million in 2024
• The Luxembourg Stem Cell Therapy for Osteoarthritis market is projected to witness growth at a CAGR of 24.2% during the forecast period, with a market size of USD 0.27 million in 2024.
• The Portugal Stem Cell Therapy for Osteoarthritis market is projected to witness growth at a CAGR of 23.9% during the forecast period, with a market size of USD 0.19 million in 2024.
• The Greece Stem Cell Therapy for Osteoarthritis market is projected to witness growth at a CAGR of 24.4% during the forecast period, with a market size of USD 0.11 million in 2024.
• Rest of Europe's Stem Cell Therapy for Osteoarthritis market is projected to witness growth at a CAGR of 22.8% during the forecast period, with a market size of USD 1.37 million in 2024.

Asia Pacific Stem Cell Therapy for Osteoarthritis Market Analysis

According to Cognitive Market Research, the global Stem Cell Therapy for Osteoarthritis market size was estimated at USD 29.5 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 6.79 million in 2024 and will grow at a compound annual growth rate (CAGR) of 27.6% from 2024 to 2031.

• According to Cognitive Market Research, the China Stem Cell Therapy for Osteoarthritis market size was valued at USD 3.05 million in 2024 and is projected to grow at a CAGR of 27.1% during the forecast period. China has a long history of treating a wide range of illnesses with traditional medicine. Stem cell therapy may become more widely accepted among patients if researchers can figure out how to incorporate it with conventional Chinese medicine procedures.
• The Japan Stem Cell Therapy for Osteoarthritis market is projected to witness growth at a CAGR of 26.1% during the forecast period, with a market size of USD 0.94 million in 2024.
• The India Stem Cell Therapy for Osteoarthritis market had a market share of USD 0.81 million in 2024 and is projected to grow at a CAGR of 29.4% during the forecast period. Investments in constructing and modernizing hospitals and other medical facilities are rising in India. This may improve the conditions for applying stem cell treatments.
• The South Korea Stem Cell Therapy for Osteoarthritis market is projected to witness growth at a CAGR of 26.7% during the forecast period, with a market size of USD 0.68 million in 2024.
• The Australia Stem Cell Therapy for Osteoarthritis market is projected to witness growth at a CAGR of 27.3% during the forecast period, with a market size of USD 0.35 million in 2024.
• The South East Asia Stem Cell Therapy for Osteoarthritis market is projected to witness growth at a CAGR of 28.6% during the forecast period, with a market size of USD 0.47 million in 2024.
• The Rest of Asia Pacific Stem Cell Therapy for Osteoarthritis market is projected to witness growth at a CAGR of 27.4% during the forecast period, with a market size of USD 0.48 million in 2024.

South America Stem Cell Therapy for Osteoarthritis Market Analysis

According to Cognitive Market Research, the global Stem Cell Therapy for Osteoarthritis market size was estimated at USD 29.5 Million, out of which Latin America market of more than 5% of the global revenue with a market size of USD 1.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 25.0% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Stem Cell Therapy for Osteoarthritis market size was valued at USD 0.63 million in 2024 and is projected to grow at a CAGR of 25.6% during the forecast period. Brazil is seeing a rise in governmental and private sector investments in healthcare research and development. This may result in increased financing for osteoarthritis-specific stem cell treatment research.
• Argentina's Stem Cell Therapy for Osteoarthritis market had a market share of USD 0.25 million in 2024 and is projected to grow at a CAGR of 25.9% during the forecast period. Stem cell therapy clinical trials in Argentina can produce useful data unique to the country's population and open the door for broader market acceptance if they are supported and streamlined.
• Colombia's Stem Cell Therapy for Osteoarthritis market is projected to witness growth at a CAGR of 24.8% during the forecast period, with a market size of USD 0.13 million in 2024.
• Peru Stem Cell Therapy for Osteoarthritis market is projected to witness growth at a CAGR of 25.2% during the forecast period, with a market size of USD 0.12 million in 2024.
• Chile's Stem Cell Therapy for Osteoarthritis market is projected to witness growth at a CAGR of 25.3% during the forecast period, with a market size of USD 0.11 million in 2024.
• The Rest of Latin America's Stem Cell Therapy for Osteoarthritis market is projected to witness growth at a CAGR of 24.1% during the forecast period, with a market size of USD 0.24 million in 2024.

Middle East Stem Cell Therapy for Osteoarthritis Market Analysis

According to Cognitive Market Research, the global Stem Cell Therapy for Osteoarthritis market size was estimated at USD 29.5 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 0.59 million in 2024 and will grow at a compound annual growth rate (CAGR) of 25.3% from 2024 to 2031.

• The GCC Countries Stem Cell Therapy for Osteoarthritis market is projected to witness growth at a CAGR of 26.1% during the forecast period, with a market size of USD 0.25 million in 2024. Growing disposable wealth in GCC nations enables patients to pursue cutting-edge, possibly more costly treatments like stem cell therapy. In addition, the area is becoming known as a center for medical tourism, drawing people seeking specialist care from abroad.
• The Egypt Stem Cell Therapy for Osteoarthritis market is projected to witness growth at a CAGR of 25.6% during the forecast period, with a market size of USD 0.06 million in 2024.
• The South Africa Stem Cell Therapy for Osteoarthritis market is projected to witness growth at a CAGR of 26.3% during the forecast period, with a market size of USD 0.09 million in 2024. South African research institutes may collaborate with foreign partners to pool resources and quicken the development of osteoarthritis stem cell treatments.
• The Turkey Stem Cell Therapy for Osteoarthritis market is projected to witness growth at a CAGR of 24.8% during the forecast period, with a market size of USD 0.05 million in 2024.
• The Nigeria Stem Cell Therapy for Osteoarthritis market is projected to witness growth at a CAGR of 24.4% during the forecast period, with a market size of USD 0.06 million in 2024.
• The Rest of the MEA Stem Cell Therapy for Osteoarthritis market is projected to witness growth at a CAGR of 24.3% during the forecast period, with a market size of USD 0.07 million in 2024.

Stem Cell Therapy for Osteoarthritis Market Analysis

Stem Cell Therapy for Osteoarthritis Market Type Segment Analysis

According to Cognitive Market Research, Primary Osteoarthritis is the dominating category. The goal of stem cell therapy for primary osteoarthritis is to treat the degenerative changes in the joints without focusing on the underlying cause. It aims to repair damaged tissues and cartilage, which may lessen discomfort and enhance joint function. This method provides a less invasive substitute for common treatments, including painkillers and surgery. The market for stem cell therapy for primary osteoarthritis is growing to address the rising demand for long-term, effective solutions due to breakthroughs in stem cell research and mounting clinical evidence supporting its usefulness.

Secondary Osteoarthritis is the fastest-growing category in the Stem Cell Therapy for Osteoarthritis market. The goal of stem cell therapy for secondary osteoarthritis is to address joint deterioration brought on by underlying diseases, including inflammatory arthritis (such as rheumatoid arthritis), developmental defects, or past injuries. It attempts to repair damaged tissues and cartilage in order to reduce discomfort and increase the range of motion. While targeting particular causal variables, this therapy method offers prospective benefits akin to those of primary osteoarthritis. Stem cell therapy for secondary osteoarthritis shows potential for offering individualized and successful therapies for patients with a variety of underlying diseases, pending further study and clinical studies.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Stem Cell Therapy for Osteoarthritis Industry. Request a Free Sample PDF!

Stem Cell Therapy for Osteoarthritis Market Therapy Type Segment Analysis

According to Cognitive Market Research, the dominating category is Monotherapy. Because stem cell therapy is minimally invasive and has the potential to have regenerative benefits, it is in high demand for the treatment of osteoarthritis. It targets the underlying cause of cartilage deterioration in an effort to reduce discomfort and enhance joint function. Patients prefer therapies that provide long-term alleviation and increased mobility over conventional treatments like surgery and painkillers. Monotherapy with stem cell therapy is becoming more popular for treating osteoarthritis because of the expanding body of clinical evidence demonstrating its effectiveness.

The fastest-growing category in the Stem Cell Therapy for Osteoarthritis market is Combination therapy. Combining stem cell therapies with additional modalities like growth factors, platelet-rich plasma (PRP), or scaffolds to improve therapeutic outcomes is known as combination therapy in the osteoarthritis stem cell treatment industry. This method seeks to lessen inflammation, enhance joint function, and cooperatively encourage tissue regeneration. Because combination therapy addresses both the symptoms and underlying causes of osteoarthritis, it is preferred. Growing evidence from clinical studies and research confirms its effectiveness, which is boosting demand from patients and healthcare professionals looking for more efficient treatment alternatives.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Stem Cell Therapy for Osteoarthritis Application Segment Analysis

Stem Cell Therapy for Osteoarthritis Market Application Segment Analysis

According to Cognitive Market Research, the dominating category is Allogeneic. Stem cells produced from donors are used in allogeneic applications, which are part of the osteoarthritis stem cell therapy industry. This method has several benefits over autologous therapy, including cost-effectiveness, standardized quality, and instant availability. For patients without access to viable autologous stem cell sources, it broadens their range of therapeutic alternatives. The difficulties lie in the regulatory complexity and possible immunological reactions. Research is now being conducted to address these problems and improve the viability and safety of allogeneic stem cell therapies for osteoarthritis and other degenerative joint disorders.

The fastest-growing category in the Stem Cell Therapy for Osteoarthritis market is Autologous. The use of a patient's stem cells for treatment is known as an autologous application in the market for stem cell therapy for osteoarthritis. This method minimizes immunological rejection risks and ethical issues related to donor-derived cells by utilizing the patient's biological material. Treatment effectiveness and security could be enhanced by autologous stem cell therapy, which provides individualized treatment options catered to each patient's needs. Yet, because cell separation and culture are required, it might require more expensive and time-consuming procedures.

• Allogeneic
• Autologous

Stem Cell Therapy for Osteoarthritis End-Use Segment Analysis

Stem Cell Therapy for Osteoarthritis Market End-Use Segment Analysis

According to Cognitive Market Research, the dominating category is Hospitals. Hospitals offer specialized facilities for administering stem cell treatments, making them important end-users in the stem cell therapy for osteoarthritis market. By utilizing cutting-edge medical resources and knowledge, they provide complete care, from diagnosis to treatment. Hospitals are essential for carrying out clinical trials, putting treatment plans into action, and guaranteeing patient security and oversight. Their participation encourages cooperation between academic institutions and biotech companies, propelling the development of stem cell treatments. Hospitals are expanding their regenerative medicine application skills in response to growing demand.

The fastest-growing category in the Stem Cell Therapy for Osteoarthritis market is the Clinics. Clinics play a key role as end-users in the osteoarthritis stem cell therapy market because they provide specialized care outside of conventional hospital settings. These clinics serve patients looking for non-invasive ways to manage their osteoarthritis by offering easy access to regenerative therapies. Clinics use cutting-edge methods for isolating, culturing, and administering stem cells with an emphasis on individualized care. To guarantee successful treatment outcomes, they frequently work in conjunction with research facilities and medical practitioners. Clinics are essential for increasing access to stem cell treatments as knowledge and demand for novel therapies rise.

• Hospitals
• Clinics

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion